Open PostDoc position on Causal data analysis of in-silico trials in the Inria team EPIONE

Application deadline 18 September 2022

Open Post Doctoral position in the Inria team EPIONE (E-Patient for E-medicine, at Centre Inria d'Université Côte d'Azur, France) within the context of the European project SimCardioTest, to develop causal data analysis methods of the in silico generated data, and support the adoption of Computer Modeling & Simulation as reliable tools to generate scientific evidences relevant for the clinical evaluation of the targeted cardiac drugs and devices.

During the project, the candidate will be in charge of:

  • Master, implement and test causal machine learning methods for causal discovery on the in-silico generated data
  • Propose and develop improvement of state-of-the-art methods to tackle challenges such as multimodality and heterogeneity of the available datasets, and the longitudinal component
  • Focus on interpretability and transferability of methods/results to inform clinical trials design and assessment
  • Present the works' progress to SimCardioTest partners and to the broader scienific community
  • Write and publish scientific works (international conferences and journals)

The candidate should hold a PhD in computer science, statistics or applied mathematics. We are looking for a highly motivated candidate with a proven experience in statistics, Bayesian learning and biomedical data analysis. Programming skills (Python) are mandatory. Previous work experience in the medical field context is highly recommended, and a previous work on cardiac modeling and/or pharmacokinetics modeling is appreciated. Strong communication abilities are required.

To know more and apply, visit https://recrutement.inria.fr/public/classic/fr/offres/2022-05241

Date: 25/07/2022 | Tag: | News: 1343 of 1626
All news

News

  • 05/11/2024

    "In silico trials: an updated SWOT Analysis" released by In Silico World

    • The document comprehensively examines the strengths, weaknesses, opportunities, and threats for In Silico Trials in healthcare, providing a roadmap to help biomedical companies navigate and adopt these innovative methodologies. -Read more-
  • 31/10/2024

    In the literature: October 2024 highlights

    • Click here to read some interesting recently published papers from our community. If you have published an article in the field of in silico medicine, send it to us: we will include it in this section of the newsletter! -Read more-
  • 31/10/2024

    Joint motion for a resolution to revise the Medical Devices Regulation

    • The European Parliament has voted with a large majority to urge the European Commission to implement critical amendments to the EU Medical Device Regulation (MDR) by the first quarter of 2025. The drive for reform is intended to tackle pressing issues in the regulation, which has been criticised for its excessive bureaucracy and impact on patient care, jobs, and innovation in the medical device sector. -Read more-
  • 31/10/2024

    EU Budget for 2025 Prioritizes Research, Health, Education, and Climate Action

    • The European Parliament has presented their draft budget demanding an EU budget for 2025 that focuses on improving people's lives, boosting competitiveness, and addressing current challenges. MEPs are proposing a budget of nearly €201 billion, which exceeds the European Commission's initial proposal of around €199.76 billion. -Read more-
More news

Events

More events
newsletter

Subscribe to the VPH Institute Newsletter

ARCHIVE

Read all the newsletters of the VPH Institute

GO